Companies
Waters Corporation
its BioResolve Peptide and GTxResolve Lipid columns (230 Å) deliver up to 3x faster GLP-1 characterization and 2x faster LNP analysis, with a global launch from June 2026.
- Country
- United States
- Ticker
- NYSE: WAT
ISO 9001
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaepareachemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | $3.165 billion (total net sales) (2025-12-31) | firmsworld.com |
| Headcount | approximately 7,900 employees (2025-12-31) | firmsworld.com |
| Production site | Milford, MA; Taunton, MA; Wexford, Ireland; Wilmslow, England; Birmingham, England; Golden, CO; New Castle, DE; Eden Prairie, MN; Lindon, UT; Hüllhorst, Germany; Santa Barbara, CA; Singapore (outsourced) | firmsworld.com · sec.gov |
| Certification | Various facilities are ISO 9001:2015, ISO 13485:2016, ISO 45001:2018, ISO 14001:2015, ISO/IEC 17025:2017, ISO/IEC 17034:2016, and LEED-certified | sec.gov |
| Capacity | Expanded manufacturing capacity with a $251 million investment in Taunton and a new facility in Birmingham, UK; Taunton site nearly tripled manufacturing footprint (2024-02-01) | businesswire.com · sec.gov |
Independent sources: businesswire.com · firmsworld.com · sec.gov
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Automated sample preparation for analytics | analytics-pat | Low | → |
| Bioprocess analytics & PAT (process analytical technology) | analytics-pat | Low | → |
| HPLC/UPLC instruments for biopharma | analytics-pat | Low | → |
| Mass spectrometers for biopharma characterization | analytics-pat | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.